Aprea Therapeutics
APRE
#11003
Rank
โ‚ฌ6.3 M
Marketcap
0,44ย โ‚ฌ
Share price
-0.40%
Change (1 day)
-59.60%
Change (1 year)

EPS for Aprea Therapeutics (APRE)

EPS in 2023 (TTM): -5,34ย โ‚ฌ

According to Aprea Therapeutics's latest financial reports the company's current EPS (TTM) is -0,96ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -86,66ย โ‚ฌ a decrease over its 2021 EPS that were of -31,17ย โ‚ฌ.

EPS history for Aprea Therapeutics from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-5,34ย โ‚ฌ-93.84%
2022-86,66ย โ‚ฌ177.97%
2021-31,17ย โ‚ฌ-31.1%
2020-45,25ย โ‚ฌ70.91%
2019-26,47ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amedisys
AMED
2,32ย โ‚ฌ-341.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
1,34ย โ‚ฌ-239.81%๐Ÿ‡บ๐Ÿ‡ธ USA